Literature DB >> 29653348

Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.

Samira S Valvassori1, Daniela V Bavaresco2, Gustavo Feier2, Kelen Cechinel-Recco2, Amanda V Steckert2, Roger B Varela2, Cenita Borges2, Milena Carvalho-Silva3, Lara M Gomes3, Emílio L Streck3, João Quevedo4.   

Abstract

The present study aims to investigate the oxidative stress parameters in isolated mitochondria, as well as looking at mitochondrial complex activity in patients with Bipolar Disorder (BD) during depressive or euthymic episodes. This study evaluated the levels of mitochondrial complex (I, II, II-III and IV) activity in lymphocytes from BD patients. We evaluated the following oxidative stress parameters: superoxide, thiobarbituric acid reactive species (TBARS) and carbonyl levels in submitochondrial particles of lymphocytes from bipolar patients. 51 bipolar patients were recruited into this study: 34 in the euthymic phase, and 17 in the depressive phase. Our results indicated that the depressive phase could increase the levels of mitochondrial superoxide, carbonyl and TBARS, and superoxide dismutase, and could decrease the levels of mitochondrial complex II activity in the lymphocytes of bipolar patients. It was also observed that there was a negative correlation between the Hamilton Depression Rating Scale (HDRS) and complex II activity in the lymphocytes of depressive bipolar patients. In addition, there was a positive correlation between HDRS and superoxide, superoxide dismutase, TBARS and carbonyl. Additionally, there was a negative correlation between complex II activity and oxidative stress parameters. In conclusion, our results suggest that mitochondrial oxidative stress and mitochondrial complex II dysfunction play important roles in the depressive phase of BD.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar disorder; Depression; Mitochondria; Oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29653348     DOI: 10.1016/j.psychres.2018.03.089

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism.

Authors:  Tereza Cikánková; Zdeněk Fišar; Jana Hroudová
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-19       Impact factor: 3.000

Review 2.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca2+-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior.

Authors:  Luiza Spohr; Mayara Sandrielly Pereira Soares; Natália Pontes Bona; Nathalia Stark Pedra; Alethéa Gatto Barschak; Rafaela Martins Alvariz; Marcia Vizzotto; Claiton Leoneti Lencina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2022-01-19       Impact factor: 3.584

Review 4.  Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.

Authors:  Kosma Sakrajda; Aleksandra Szczepankiewicz
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 5.  Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.

Authors:  Luiz Arthur Rangel Cyrino; Daniela Delwing-de Lima; Oliver Matheus Ullmann; Thayná Patachini Maia
Journal:  Front Behav Neurosci       Date:  2021-02-26       Impact factor: 3.558

Review 6.  Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.

Authors:  Sahithi Madireddy; Samskruthi Madireddy
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 7.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

8.  Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people.

Authors:  Ivo Emilio da Cruz Jung; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Alexis Trott; Lucien J Houenou; Bárbara Osmarin Turra; Thiago Duarte; Raquel de Souza Praia; Ednea Aguiar Maia-Ribeiro; Jaqueline da Costa Escobar Piccoli; Claudia Giugliano Bica; Marta Maria Medeiros Frescura Duarte
Journal:  Mol Genet Genomic Med       Date:  2019-12-31       Impact factor: 2.183

9.  The Prevalence of Sarcopenia in Bipolar Disorder.

Authors:  Feridun Bulbul; Irfan Koca; Lut Tamam; Mehmet Emin Demirkol; Soner Cakmak; Emre Ersahinoglu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-08       Impact factor: 2.570

Review 10.  Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings.

Authors:  Giselli Scaini; Samira S Valvassori; Alexandre P Diaz; Camila N Lima; Deborah Benevenuto; Gabriel R Fries; Joao Quevedo
Journal:  Braz J Psychiatry       Date:  2020 Sep-Oct       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.